No Detail Found!

The novel effect of propranolol in glibenclamide induced hepatotoxicity

Author(s)
Hina Abrar Dow College of Pharmacy, Dow University of Health Sciences (Ojha Campus), Karachi, Pakistan; Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
Adeel Arsalan Faculty of Pharmacy, Ziauddin Medical University,Karachi,Pakistan
Hina Yasin Dow College of Pharmacy, Dow University of Health Sciences (Ojha Campus),Karachi,Pakistan
Syed Ijaz Hussain Zaidi Department of Pharmacology, Bahria University Medical & Dental College,Karachi,Pakistan
Sadaf Ibrahim Faculty of Pharmacy, Ziauddin Medical University,Karachi,Pakistan
Kiran Qadeer Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University,Karachi,Pakistan
Hira Naeem Baqai Institute of Pharmaceutical Sciences, Baqai Medical University,Karachi,Pakistan
Kaneez Fatima Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University,Karachi,Pakistan
Hina Tabassum Dow College of Pharmacy, Dow University of Health Sciences (Ojha Campus),Karachi,Pakistan
Syed Naimul Hasan Naqvi Baqai Institute of Pharmaceutical Sciences, Baqai Medical University,Karachi,Pakistan
Abstract
Glibenclamide (GBC) has been associated with hepatotoxicity in humans. This study conducted on rabbits to evaluate the hepatotoxicity of GBC alone and in combination therapy with propranolol (PPL). Liver enzymes like alanine transaminase (ALT), alkaline phosphatase (ALP) and gamma-glutamyltransferase (?-GT) and bilirubin (BRB) are used to evaluate hepatotoxicity associated with GBC. Histological findings, micrometry and scanning electron microscopy (SEM) used to find hepatotoxicity by GBC and with PPL. GBC caused significant elevation of liver functions as compared to control (p<0.005). PPL reduced the level of serum ALT, ALP, ?GT and BRB when administered with GBC (p<0.005). The results prevailed that there is a significant change in hepatic cells structure and significant change in its diameter of nucleus (p<0.05). The necrosis and granuloma with decreased in number of hepatic cells were observed in GBC treated rabbits. However, the combination of GBC with PPL has shown healthy and nearly similar structure as that of controlled group and confirmed by SEM microscopy. PPL reduced the blood flow to hepatic portal system and thus, avoid the noxious substances to liver. It is affirmed that the use of PPL offered beneficial effect on hepatotoxic drugs.
Publication Details
Page(s) 1871-1878
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP4, Year: 2020

Request the full text from PASTIC

Keywords
Type II diabetes mellitus, Glibenclamide, Scanning electron microscopy, histological studies, Hepatotoxicity, micrometry
References
Abdelmoneim AS,Eurich DT,Gamble JM,Johnson JA,Seubert JM,Qiu W,Simpson SH .2014 .Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: A nested case-control study. Diabetes Obes. Metab., 16(1) : 22-29.
Alotaibi MR,Fatani AJ,Almnaizel AT,Ahmed MM,Abuohashish HM,Al-Rejaie SS .2019 .In vivo assessment of combined effects of glibenclamide and losartan in diabetic rats. Med, 28 : 178-185.
Alturkistani HA,Tashkandi FM,Mohammedsaleh ZM .2016 .Histological stains: A literature review and case study. Glob. J. Health Sci., 8(3) : 72-79.
Baiges A,Hernández-Gea V,Bosch J .2018 .Pharmacologic prevention of variceal bleeding and rebleeding. Hepatol. Int., 12(Suppl 1) : 68-80.
Brunner F,Berzigotti A,Bosch J .2017 .Prevention and treatment of variceal haemorrhage in 2017. , 37(Suppl 1) : 104-115.
Channa M and Janjua M .2003 .Effects of ciprofloxacin on foetal hepatocytes. JPMA, 53 : 448-450.
Chen J,Marciniak TA,Radford MJ,Wang Y,Krumholz HM Y .1999 .Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients1: Results from the national cooperative cardiovascular project. J. Am. Coll. Cardiol., 34 : 1388-1394.
Chounta A,Zouridakis S,Ellinas C,Tsiodras S,Zoumpouli C,Kopanakis S,Giamarellou H S .2005 .Cholestatic liver injury after glimepiride therapy. J. Hepatol., 42 : 944-946.
Dourakis SP,Tzemanakis E,Sinani C,Kafiri G,Hadziyannis SJ .2000 .Gliclazide-induced acute hepatitis. Eur. J. Gastroenterol. Hepatol., 12 : 119.
Dungan K,Merrill J,Long C,Binkley P C .2019 .Effect of beta blocker use and type on hypoglycemia risk among hospitalized insulin requiring patients. Cardiovasc. Diabetol, 18 : 163.
El-Refaei MF,Abduljawad SH,Alghamdi AH .2014 .Alternative medicine in diabetes role of angiogenesis, oxidative stress and chronic inflammation. Rev. Diabet. Stud., 11(3-4) : 231-244.
Feroz Z,Khan RA .2013 .Hepatoprotective effect of herbal drug on CCl 4 induced liver damage. Pak. J. Pharm. Sci., 26(1) : 99-103.
Garcia-Compean D,Gonzalez-Gonzalez JA,LavalleGonzalez FJ,Gonzalez-Moreno EI,Maldonado-Garza HJ,Villarreal-Perez JZ .2015 .The treatment of diabetes mellitus of patients with chronic liver disease. Annal. Hepatol., 14(6) : 780-788.
Ie D ,Apis F .2015 .(Hymenoptera: Apidae). J. Appl. Nat. Sci., 7 : 324-327.
Diabetes Federation (IDF) Diabetes International,Atlas International .2019 .. (Access on 31 January, : .
Jayaraman R,Subramani S,Sheik Abdullah SH,Udaiyar M .2018 .Antihyperglycemic effect of hesperetin, a citrus flavonoid, extenuates hyperglycemia and exploring the potential role in antioxidant and antihyperlipidemic in streptozotocininduced diabetic rats. Biomed, 97 : 98-106.
Kamal P and Bhabhra R .2019 .Glipizide induced hepatotoxicity: A case report and review of literature. J. Diab. Metab. Disord., 6 : 028.
Kharroubi AT,Darwish HM .2015 .Diabetes mellitus: The epidemic of the century. World J. Diabetes., 6(6) : 850-867.
Kolaric TO,Nincevic V,Smolic R,Martina Smolic M and Wu GY R .2019 .Mechanisms of hepatic cholestatic drug injury. J. Clin. Transl, 7(1) : 86-92.
Li R,Bi Y,Vildhede A,Scialis RJ,Mathialagan S,Yang X,Marroquin LD,Lin J,Varma MVS .2017 .Transporter-mediated disposition, clinical pharmacokinetics and cholestatic potential of glyburide and its primary active metabolites. Drug Metab. Disposit, 45(7) : 737-747.
Luo X,Wang Z,Tsauo J,Zhou B,Zhang H,Li X .2015 .Advanced cirrhosis combined with portal vein thrombosis: A randomized trial of tips versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal variceal bleeding. , 276(1) : 286-293.
Lv W,Wang X,Xu Q,Lu W .2020 .Mechanisms and characteristics of sulfonylureas and glinides. Curr. Top. Med, 20(1) : 37-56.
Murtey MD,Ramasamy P,Janecek M,Kral R .2016 .Sample preparations for scanning electron microscopy life sciences, modern electron microscopy. In: Physical and Life Sciences, : .
Notenboom S,Weigand KM,Proost JH,van Lipzig MHM,van den Broek PHH,Greupink R,Russel FGM,Geny MM,Groothuis GMM .2018 .Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs. Eur. J. Pharm. Sci., 115 : 175-184.
Papazafiropoulou A,Melidonis A .2019 .Antidiabetic agents in patients with hepatic impairment. World J. Meta-Anal., 7(8) : 380-388.
Parasuraman S,Raveendran R,Kesavan R .2010 .Blood sample collection in small laboratory animals. J. Pharmacol. Pharmacother., 1(2) : 87-93.
Petrogiannopoulos C and Zacharof A .1997 .Glibenclamide and liver disease. Diab. Care, 20 : 1215.
Phemister J,Kapila A,Patel P,Mckinney JDO,Young M .2014 .Glyburide-induced cholestatic hepatitis. Ame. J. Gastroenterol., 109 : S367.
Rahmani AH,Hasanzadeh R,Nazari P .2016 .The complications and outcomes of oral antidiabetic drug poisoning in patients hospitalized at Razi hospital. World J. Pharm. Res., 5(11) : 153-160.
Sarges P,Steinberg JM,Lewis JH JM .2016 .Druginduced liver injury: Highlights from a review of the 2015 literature. , 39(9) : 801-821.
Scheen AJ .2014 .Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease. Expert Opin. Drug Metab. Toxicol., 10(6) : 839-857.
Sen S,Chakraborty R,De B R .2016 .Management of diabetes mellitus. In: Diabetes Mellitus in 21st Century. Springer Science+Business Media Singapore, : 13-22.
Sharma V,Janmeda P .2013 .Chemopreventive Role of Euphorbia neriifolia (Linn) and its isolated flavonoid against N-nitrosodiethylamine‒induced renal histopathological damage in male mice. Toxicol. Int., 20 : 101-107.
Sola D,Rossi L,Schianca GPC,Maffioli P,Bigliocca M,Mella R,Corliano F,Fra GP,Bartoli E,Derosa G .2015 .Sulfonylureas and their use in clinical practice. Arch. Med, 11(4) : 840-848.
Stokes A,Preston SH .2017 .Deaths attributable to diabetes in the United States: Comparison of data sources and estimation approaches. PLoS One, 12(1) : e0170219.
Subramanian G,Walmsley D,Blewitt R D .2003 .Gliclazide-induced hepatitis. Pract. Diab. Int., 20 : 18-20.
Swamy S,Krishna K,Nidavani RB K .2013 .Reversal of rosiglitazone hepatotoxicity by silymarin on rats. Int. J.Pharm. Sci. Res, 4 : 2301-2307.
Tholakanahalli VN,Potti A,Heyworth MF .1998 .Glibenclamide‒induced cholestasis. West. J. Med, 168 : 274-277.
Tolman KG,Freston JW,Kupfer S,Perez A .2009 .Liver safety in patients with type 2 diabetes treated with pioglitazone. Drug Saf, 32 : 787-800.
Tran L,Zielinski A,Roach AH,Jeneda JA,Householder AM,Cole EE,Atway EE,Amornyard M,Accursi ML,Shieh SW,Thompson EE .2015 .Pharmacologic treatment of type 2 diabetes: Oral medications. , 49(5) : 540-556.
van Basten J,van Hoek B,Zeijen R,Stockbrügger R .1992 .Glyburide-induced cholestatic hepatitis and liver failure. Case-report and review of the literature.Neth. J. Med, 40 : 305-307.
Villanueva C,Aracil C,Colomo A,Hernandez-Gea V,Lopez-Balaguer JM,Alvarez-Urturi C,Torras X,Balanzo J,Guarner C .2009 .Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterol., 137(1) : 119-128.
- .2020 .The top 10 causes of death. Accese on 30th June, : .
.2020 .. Accese on 30th June, : .
Zaman R,Kendall MJ,Biggs PI .1982 .The effect of acebutolol and propranolol on the hypoglycaemic. , : .
. .action of glibenclamide. Br. J. Clin. Pharmacol, 13(4) : .
0

Citations

0

Downloads

15

Views